cv 3988 has been researched along with Cornea Injuries in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, IW; Jung, WK; Lee, CM; Lee, DS; Lee, YM; Na, G; Park, SG; Park, WS; Seo, SK; Yang, JW; Yea, SS | 1 |
Bazan, HE; Tao, Y | 1 |
2 other study(ies) available for cv 3988 and Cornea Injuries
Article | Year |
---|---|
Inhibitory effects of the platelet-activating factor receptor antagonists, CV-3988 and Ginkgolide B, on alkali burn-induced corneal neovascularization.
Topics: Alkalies; Animals; Cell Movement; Cells, Cultured; Corneal Injuries; Corneal Neovascularization; Corneal Opacity; Eye Burns; Female; Ginkgolides; Human Umbilical Vein Endothelial Cells; Humans; Lactones; Mice; Neovascularization, Physiologic; Neutrophils; Phospholipid Ethers; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; RNA, Messenger | 2015 |
PAF antagonists as possible inhibitors of corneal epithelial defects and ulceration.
Topics: Azepines; Cornea; Corneal Injuries; Diterpenes; Enzyme Activation; Epithelium; Extracellular Matrix Proteins; Fibrinolytic Agents; Ginkgolides; Lactones; Metalloendopeptidases; Phospholipid Ethers; Platelet Activating Factor; Thienopyridines; Triazoles; Urokinase-Type Plasminogen Activator; Wound Healing | 1997 |